NCT02190058View on ClinicalTrials.gov

Multiple Dose Study of DS-1971a

PHASE1CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions

Healthy

Interventions

DRUG

DS-1971a

suspension

DRUG

placebo

placebo matching DS-1971a

Trial Locations (1)

Unknown

Hammersmith Medicines Research Ltd., London

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Daiichi Sankyo

INDUSTRY

NCT02190058 - Multiple Dose Study of DS-1971a | Biotech Hunter | Biotech Hunter